• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gender-Affirming Hormone Therapy for the Trans, Gender Diverse, and Nonbinary Community: Coordinating World Professional Association for Transgender Health and Informed Consent Models of Care.为跨性别、性别多元和非二元性别人群提供性别肯定激素治疗:世界跨性别健康专业协会与知情同意护理模式的协调
Transgend Health. 2023 Mar 31;8(2):137-148. doi: 10.1089/trgh.2021.0069. eCollection 2023 Apr.
2
Gender-affirming care, mental health, and economic stability in the time of COVID-19: A multi-national, cross-sectional study of transgender and nonbinary people.在 COVID-19 期间的性别肯定护理、心理健康和经济稳定:一项对跨性别和非二元性别者的多国、横断面研究。
PLoS One. 2021 Jul 9;16(7):e0254215. doi: 10.1371/journal.pone.0254215. eCollection 2021.
3
The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction.知情同意模式下的性别肯定激素治疗的护理与患者的高度满意度相关。
J Sex Med. 2021 Jan;18(1):201-208. doi: 10.1016/j.jsxm.2020.10.020. Epub 2020 Nov 26.
4
Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.性别肯定激素疗法与跨性别和非二元青年的抑郁、自杀念头和自杀未遂的关联。
J Adolesc Health. 2022 Apr;70(4):643-649. doi: 10.1016/j.jadohealth.2021.10.036. Epub 2021 Dec 14.
5
Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care.跨性别和非二元性别青年接受性别肯定护理的心理健康结果。
JAMA Netw Open. 2022 Feb 1;5(2):e220978. doi: 10.1001/jamanetworkopen.2022.0978.
6
Transgender and Nonbinary Individuals' Perceptions Regarding Gender-Affirming Hormone Therapy and Cardiovascular Health: A Qualitative Study.跨性别和非二元性别个体对性别肯定激素治疗与心血管健康的看法:一项定性研究。
Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e011024. doi: 10.1161/CIRCOUTCOMES.124.011024. Epub 2024 Jul 18.
7
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.《跨性别和性别多样化人群健康照护标准》第8版
Int J Transgend Health. 2022 Sep 6;23(Suppl 1):S1-S259. doi: 10.1080/26895269.2022.2100644. eCollection 2022.
8
Understanding Their Experiences: Psychosocial Functioning of Nonbinary and Binary Youth at the Time of Hormone Readiness Assessment.理解他们的经历:激素准备评估时的非二元和二元青年的心理社会功能。
LGBT Health. 2024 Feb-Mar;11(2):164-169. doi: 10.1089/lgbt.2023.0056. Epub 2023 Oct 10.
9
Readiness assessments for gender-affirming surgical treatments: A systematic scoping review of historical practices and changing ethical considerations.性别确认手术治疗的准备情况评估:对历史实践和不断变化的伦理考量的系统范围综述
Front Psychiatry. 2022 Oct 20;13:1006024. doi: 10.3389/fpsyt.2022.1006024. eCollection 2022.
10
The gender affirmative lifespan approach (GALA): A framework for competent clinical care with nonbinary clients.性别肯定性终身方法(GALA):针对非二元性别的服务对象提供有效临床护理的框架。
Int J Transgend. 2019 Jan 16;20(2-3):275-288. doi: 10.1080/15532739.2018.1485069. eCollection 2019.

引用本文的文献

1
Outcome measurement for gender-affirming care in Canada: a systematic review.加拿大性别肯定治疗的结果测量:一项系统综述。
BMJ Open. 2025 Mar 12;15(3):e091135. doi: 10.1136/bmjopen-2024-091135.
2
Access to transition-related health care among transmasculine people in India: A mixed-methods investigation.印度跨性别男性获得与过渡相关医疗保健的情况:一项混合方法研究。
PLOS Glob Public Health. 2024 Oct 29;4(10):e0003506. doi: 10.1371/journal.pgph.0003506. eCollection 2024.
3
Adherence to Gender Affirming Hormone Therapy in Transgender Adolescents and Adults: A Retrospective Cohort Study.跨性别青少年和成人中性别肯定激素治疗的依从性:一项回顾性队列研究。
J Clin Endocrinol Metab. 2023 Oct 18;108(11):e1236-e1244. doi: 10.1210/clinem/dgad306.

本文引用的文献

1
The Complexities of Categorizing Gender: A Hierarchical Clustering Analysis of Data from the First Australian Trans and Gender Diverse Sexual Health Survey.性别分类的复杂性:来自澳大利亚首次跨性别及性别多样化人群性健康调查数据的层次聚类分析
Transgend Health. 2021 Apr 16;6(2):74-81. doi: 10.1089/trgh.2020.0050. eCollection 2021 Apr.
2
Trans and gender diverse people's experiences of healthcare access in Australia: A qualitative study in people with complex needs.跨性别和性别多样化人群在澳大利亚获得医疗保健的体验:有复杂需求人群的定性研究。
PLoS One. 2021 Jan 28;16(1):e0245889. doi: 10.1371/journal.pone.0245889. eCollection 2021.
3
The Health and Well-Being of Transgender Australians: A National Community Survey.澳大利亚跨性别者的健康和福利:全国社区调查。
LGBT Health. 2021 Jan;8(1):42-49. doi: 10.1089/lgbt.2020.0178. Epub 2020 Dec 9.
4
The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction.知情同意模式下的性别肯定激素治疗的护理与患者的高度满意度相关。
J Sex Med. 2021 Jan;18(1):201-208. doi: 10.1016/j.jsxm.2020.10.020. Epub 2020 Nov 26.
5
Breaking down barriers and binaries in trans healthcare: the validation of non-binary people.打破跨性别医疗保健中的障碍与二元划分:对非二元性别人群的认可。
Int J Transgend. 2019 Mar 1;20(2-3):132-137. doi: 10.1080/15532739.2018.1534075. eCollection 2019.
6
Hormone therapy for trans and gender diverse patients in the general practice setting.全科医疗环境中跨性别和性别多样化患者的激素治疗。
Aust J Gen Pract. 2020 Jul;49(7):385-390. doi: 10.31128/AJGP-01-20-5197.
7
Monash Gender Clinic: an overview of the current model of care.莫纳什性别诊所:当前护理模式概述。
Australas Psychiatry. 2020 Oct;28(5):533-535. doi: 10.1177/1039856220917079. Epub 2020 May 11.
8
Non-Binary and Binary Gender Identity in Australian Trans and Gender Diverse Individuals.澳大利亚跨性别和性别多样化个体中的非二元性别认同和二元性别认同。
Arch Sex Behav. 2020 Oct;49(7):2673-2681. doi: 10.1007/s10508-020-01689-9. Epub 2020 Apr 13.
9
Personality Disorders and Personality Profiles in a Sample of Transgender Individuals Requesting Gender-Affirming Treatments. transgender 群体中的人格障碍和人格特征。
Int J Environ Res Public Health. 2020 Feb 27;17(5):1521. doi: 10.3390/ijerph17051521.
10
Subjective Experiences of a Cisgender/Transgender Dichotomy: Implications for Occupation-Focused Research.跨性别/顺性别二分法的主观体验:对以职业为重点的研究的启示。
OTJR (Thorofare N J). 2020 Jul;40(3):211-218. doi: 10.1177/1539449220909102. Epub 2020 Feb 28.

为跨性别、性别多元和非二元性别人群提供性别肯定激素治疗:世界跨性别健康专业协会与知情同意护理模式的协调

Gender-Affirming Hormone Therapy for the Trans, Gender Diverse, and Nonbinary Community: Coordinating World Professional Association for Transgender Health and Informed Consent Models of Care.

作者信息

Solanki Pravik, Colon-Cabrera David, Barton Chris, Locke Peter, Cheung Ada S, Spanos Cassandra, Grace Julian, Erasmus Jaco, Lane Riki

机构信息

Department of General Practice, School of Public Health and Preventive Medicine, Monash University, Clayton, Australia.

Department of Anthropology, School of Social Sciences, Monash University, Clayton, Australia.

出版信息

Transgend Health. 2023 Mar 31;8(2):137-148. doi: 10.1089/trgh.2021.0069. eCollection 2023 Apr.

DOI:10.1089/trgh.2021.0069
PMID:37013095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10066762/
Abstract

PURPOSE

Before commencing gender-affirming hormone therapy, people undergo assessments through the World Professional Association for Transgender Health (WPATH) model (typically with a mental health clinician), or an informed consent (IC) model (without a formal mental health assessment). Despite growing demand, these remain poorly coordinated in Australia. We aimed to compare clients attending WPATH and IC services; compare binary and nonbinary clients; and characterize clients with psychiatric diagnoses or longer assessments.

METHODS

Cross-sectional audit of clients approved for gender-affirming treatment (March 2017-2019) at a specialist clinic (WPATH model, =212) or a primary care clinic (IC model, =265). Sociodemographic, mental health, and clinical data were collected from electronic records, and analyzed with pairwise comparisons and multivariable regression.

RESULTS

WPATH model clients had more psychiatric diagnoses (mean 1.4 vs. 1.1, <0.001) and longer assessments for hormones (median 5 vs. 2 sessions, <0.001) than IC model clients. More IC model clients than WPATH model clients were nonbinary (27% vs. 15%, =0.016). Nonbinary clients had more psychiatric diagnoses (mean 1.7 vs. 1.1, <0.001) and longer IC assessments (median 3 vs. 2 sessions, <0.001) than binary clients. Total psychiatric diagnoses were associated with nonbinary identities ( 0.7, =0.001) and health care cards ( 0.4, =0.017); depression diagnoses were associated with regional/remote residence (adjusted odds ratio [aOR] 2.2, =0.011); and anxiety disorders were associated with nonbinary identities (aOR 2.8, =0.012) and inversely associated with employment (aOR 0.5, =0.016).

CONCLUSION

WPATH model clients are more likely to have binary identities, mental health diagnoses, and longer assessments than IC model clients. Better coordination is needed to ensure timely gender-affirming care.

摘要

目的

在开始性别肯定激素治疗之前,人们需通过世界跨性别健康专业协会(WPATH)模式(通常由心理健康临床医生进行评估)或知情同意(IC)模式(无需正式心理健康评估)接受评估。尽管需求不断增长,但在澳大利亚,这些评估的协调工作仍很薄弱。我们旨在比较接受WPATH和IC服务的客户;比较二元性别和非二元性别客户;并对患有精神疾病诊断或评估时间较长的客户进行特征描述。

方法

对一家专科诊所(WPATH模式,n = 212)或一家初级保健诊所(IC模式,n = 265)在2017年3月至2019年期间批准接受性别肯定治疗的客户进行横断面审核。从电子记录中收集社会人口统计学、心理健康和临床数据,并通过成对比较和多变量回归进行分析。

结果

与IC模式客户相比,WPATH模式客户有更多的精神疾病诊断(平均1.4例对1.1例,P < 0.001),激素评估时间更长(中位数5次对2次,P < 0.001)。非二元性别客户中,IC模式客户比WPATH模式客户更多(27%对15%,P = 0.016)。与二元性别客户相比,非二元性别客户有更多的精神疾病诊断(平均1.7例对1.1例,P < 0.001),IC评估时间更长(中位数3次对2次,P < 0.001)。总的精神疾病诊断与非二元性别身份(β = 0.7,P = 0.001)和医疗保健卡(β = 0.4,P = 0.017)相关;抑郁症诊断与地区/偏远居住相关(调整优势比[aOR] 2.2,P = 0.011);焦虑症与非二元性别身份相关(aOR 2.8,P = 0.012),与就业呈负相关(aOR 0.5,P = 0.016)。

结论

与IC模式客户相比,WPATH模式客户更有可能具有二元性别身份、精神健康诊断和更长的评估时间。需要更好地协调以确保及时提供性别肯定护理。